Cutler Group LP Biohaven Pharmaceutical Holding CO Ltd. Put Options Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	SELL	$144.95 - $152.29 $1.04 Million - $1.1 Million	-7,200 Reduced 84.71%	1,300 $0
Q2 2022 Aug 04, 2022	SELL	$83.14 - $145.99 $931,168 - $1.64 Million	-11,200 Reduced 56.85%	8,500 $1,000
Q1 2022 Apr 14, 2022	BUY	$110.08 - $142.92 $1.14 Million - $1.49 Million	10,400 Added 111.83%	19,700 $174,000
Q4 2021 Jan 18, 2022	SELL	$99.73 - $148.48 $638,272 - $950,271	-6,400 Reduced 40.76%	9,300 $36,000
Q4 2020 Jan 21, 2021	BUY	$65.07 - $98.24 $631,178 - $952,928	9,700 Added 161.67%	15,700 $36,000
Q3 2020 Oct 27, 2020	BUY	$59.04 - $77.95 $265,680 - $350,775	4,500 Added 300.0%	6,000 $11,000
Q2 2020 Jul 22, 2020	SELL	$29.01 - $74.23 $87,030 - $222,690	-3,000 Reduced 66.67%	1,500 $7,000
Q1 2020 May 07, 2020	SELL	$27.51 - $57.29 $35,763 - $74,477	-1,300 Reduced 22.41%	4,500 $78,000
Q4 2019 Feb 06, 2020	SELL	$40.86 - $57.65 $89,892 - $126,830	-2,200 Reduced 27.5%	5,800 $27,000
Q3 2019 Oct 28, 2019	SELL	$37.38 - $49.47 $377,538 - $499,647	-10,100 Reduced 55.8%	8,000 $92,000
Q2 2019 Aug 09, 2019	BUY	$39.79 - $67.01 $521,249 - $877,831	13,100 Added 262.0%	18,100 $100,000
Q1 2019 May 10, 2019	BUY	$34.52 - $53.29 $172,600 - $266,450	5,000 New	5,000 $1,000
Q4 2018 Feb 05, 2019	SELL	$29.75 - $42.9 $29,750 - $42,900	-1,000 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$23.62 - $42.29 $181,874 - $325,633	-7,700 Reduced 88.51%	1,000 $1,000
Q1 2018 May 11, 2018	BUY	$22.49 - $34.56 $195,663 - $300,672	8,700 New	8,700 $4,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.